Bristol-Myers Squibb CompanyBMYNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+0.7%
5Y CAGR+0.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+0.7%/yr
vs +16.4%/yr prior
5Y CAGR
+0.1%/yr
Consistent
Acceleration
-15.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.61B | -1.7% |
| 2024 | $9.78B | +6.2% |
| 2023 | $9.21B | -2.2% |
| 2022 | $9.41B | -1.3% |
| 2021 | $9.53B | -0.3% |
| 2020 | $9.56B | +60.6% |
| 2019 | $5.95B | +15.9% |
| 2018 | $5.13B | +3.3% |
| 2017 | $4.97B | +12.8% |
| 2016 | $4.41B | - |